Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6271-6279

  Saxena, Madhukar ^a   Srivastava, Neena ^b   Banerjee, Monisha ^a  

^a UNIVERSITY OF LUCKNOW   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Interleukin 10; Interleukin 6; North Indian population; PCR RFLP; SNP; T2DM; Tumor necrosis factor

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 6; PRIMER DNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; IL 10 GENE; IL6 GENE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TNF ALPHA GENE;

ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; INDIA; INTERLEUKIN-10; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892740060     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2739-4     Document Type: Article

References (59)

1. IDF (2012) Diabetes Atlas, 5th edn
2. Banerjee M, Saxena M (2012) An overview and molecular genetics of type 2 diabetes mellitus. In: Calpis I, Frangopoulos S (eds) Type 2 diabetes causes, treatment and preventive strategies. Nova Publishers, New York, pp 1-64
3. Musa BOP, Onyemelukwe GC, Hambolu JO, Bakari AG, Anu-mah FE (2010) Cell-mediated immunity in type 2 diabetes mel-litus patients in diabetic ketoacidosis, patients with controlled type 2 diabetes mellitus and healthy control subjects. J Med Med Sci 1:290-295
4. Saxena M, Agrawal CG, Banerjee M (2012) An interleukin-10 A-592C gene polymorphism associated with type 2 diabetes: a North Indian Study. Biochem Genet 50:549-559
5. Erbilgin A, Civelek M, Romanoski CE, Pan C, Hagopian R, Berliner JA, Lusis AJ (2013) Identification of CAD candidate genes in GWAS loci and their expression in vascular cells. J Lipid Res. doi:10.1194/jlr.M037085
6. Qi L, van Dam RM, Meigs JB et al (2006) Genetic variation in IL-6 gene and type 2 diabetes:tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 15:1914-1920
7. Arora P, Garcia-Bailo B, Dastani Z et al (2011) Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet 12:95
8. Navarro-Gonzalez JF, Muros M, Mora-Fernandez C et al (2010) Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results. J Diabetes Complications 25:314-319
9. Ng DP, Nurbaya S, Ye SH et al (2008) An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients. Kidney Int 74:521-527
10. Vendrell J, Fernandez-Real JM, Gutierrez C et al (2003) A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167:257-264
11. Shiau MY, Wu CY, Huang CN et al (2003) TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 61:393-397
12. Mustapic M, Popovic Hadzija M, Pavlovic M et al (2012) Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes. Metab Brain Dis 27:507-512
13. Liu B, Yu N, Tan LS et al (2011) A study of frequency of TNF alpha gene with type 2 diabetes mellitus with chronic periodon-titis. Shanghai Kou Qiang Yi Xue 20:169-173
14. Sobti RC, Kler R, Sharma YP et al (2012) Risk of obesity and type 2 diabetes with tumor necrosis factor-a 308G/A gene polymorphism in metabolic syndrome and coronary artery disease subjects. Mol Cell Biochem 360:1-7
15. Perez-Luque E, Malacara JM, Garay-Sevilla ME et al (2012) Association of the TNF-a-308G/A polymorphism with family history of type 2 diabetes mellitus in a Mexican population. Clin Biochem 45:12-15
16. Ferreira AP, Ferreira CB, Souza VC et al (2011) Risk of glycemic disorder in elderly women adjusted by anthropometric parameters and cytokine genotypes. Rev Assoc Med Bras 57:565-569
17. Yamashina M, Kaneko Y, Maesawa C et al (2007) Association of TNF-alpha gene promoter C-857Tpolymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2diabetes. Tohoku J Exp Med 211: 251-258
18. Guzman-Flores JM, Munoz-Valle JF, Sanchez-Corona J et al (2011) Tumor necrosis factor-alpha gene promoter-308G/A and-238G/A polymorphisms in Mexican patients with type 2 diabetes mellitus. Dis Markers 30:19-24
19. Feng RN, Zhao C, Sun CH et al (2011) Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One 6:e18480
20. Vourvouhaki E, Carvalho CS (2011) A Bayesian approach to the probability of coronary heart disease subject to the-308 tumor necrosis factor-a SNP. Biosystems 105:181-189
21. Szabo GV, Acsady G (2011) Tumor necrosis factor-a-308 GA polymorphism in atherosclerotic patients. Pathol Oncol Res 17: 853-857
22. Mukhopadhyaya PN, Acharya A, Chavan Y et al (2010) Me-tagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res 9:2060-2068
23. Boraska V, Rayner NW, Groves CJ et al (2010) Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet 11:69-75
24. Kilpelainen TO, Laaksonen DE, Lakka TA et al (2010) The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study. Exp Clin Endocrinol Diabetes 118:757-759
25. Jermendy A, Korner A, Kovacs M et al (2011) PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity. J Pediatr Endocrinol Metab 24:55-59
26. Ohara M, Maesawa C, Takebe N et al (2012) Different susceptibility to insulin resistance and fatty liver depending on the combination of TNF-a C-857T and adiponectin G? 276T gene polymorphisms in Japanese subjects with type 2 diabetes. Tohoku J Exp Med 226:161-169
27. Arababadi MK, Reza Mirzaei M, Ali Sajadi SM et al (2012) Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran. Inflammation 35:797-802
28. Yin YW, Sun QQ, Zhang BB et al (2012) Association between interleukin-10 gene-592 C/A polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 5320 subjects. Hum Immunol 73:960-965
29. Paine SK, Sen A, Choudhuri S et al (2012) Association of tumor necrosis factor a, interleukin 6, andinterleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 32:1197-1203
30. Kolla VK, Madhavi G, Pulla Reddy B et al (2009) Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine 47:173-177
31. Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, Tassi V, Lauro R, Perticone F, Sesti G (2006) Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian Italian subjects. Diabetes 55:1529-1533
32. Erdogan M, Cetinkalp S, Ozgen AG et al (2012) Interleukin-10 (-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet Test Mol Biomarkers 16:91-94
33. Tsiavou A, Hatziagelaki E, Chaidaroglou A et al (2004) TNF-a, TGF-b1, IL-10, IL-6, gene polymorphisms in Latent Autoimmune Diabetes of Adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 24:591-599
34. Chang YH, Huang CN, Wu CY, Shiau MY (2005) Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 66:1258-1263
35. Kung WJ, Lin CC, Liu SH, Chaung HC (2010) Association of interleukin-10 polymorphism with cytokines in type 2 diabetes nephropathy. Diabetes Technol Ther 12:809-813
36. Forte GI, Pilato G, Vaccarino L, Sanacore M, Candore G, Romano GC, Testa R, Franceschi C, Capri M, Marra M, Bonfigli AR, Caruso C, Scola L, Lio D (2010) Risk profile in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damage related complications. Curr Pharm Des 16:898-903
37. Ezzidi I, Mtiraoui N, Kacem M et al (2009) Interleukin-10-592C/A,-819C/T and-1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol 70:401-407
38. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
39. Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and coregulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45:805-812
40. Pakala SV, Kurrer MO, Katz JD (1997) T helper 2 (Th2) cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 186:299-306
41. Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144
42. Beutler BA (1999) The role of tumor necrosis factor in health and disease. J Rheumatol 26(Suppl 57):16-21
43. Tracey KJ, Cerami A (1994) Tumor necrosis factor:a pleiotropic cytokine and therapeutic target. Ann Rev Med 45:491-503
44. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Ann Rev Immunol 10:411-452
45. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor-a: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278
46. Tsiotra PC, Tsigos C, Raptis SA (2001) TNF-alpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int J Obes Relat Metab Disord 25:1018-1026
47. Kroeger KM, Carville KS, Abraham LJ (1997) The-308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol Immunol 34:391-399
48. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 271:665-668
49. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA (1996) The expression of TNF-a by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116
50. Kubaszek A, Pihlajamaki J, Komarovski V et al (2003) Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52:1872-1876
51. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID (2002) Association of the TNF-alpha-308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 10: 401-407
52. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP, Vandenbrouke JP (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-176
53. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215
54. Shi YY, He L (2005) SHEsis is a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97-98
55. Kristiansen OP, Mandrup-Poulsen T (2005) Interleukin-6 and diabetes:the good, the bad, or the indifferent? Diabetes 54:S114-S124
56. Wilson AG, Symons JA, McDowell TL et al (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Nat Acad Sci USA 94: 3195-3199
57. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415
58. Malecka-Tendera E, Erhardt E, Molnar D (2005) Type 2 diabetes mellitus in European children and adolescents. Acta Paediatr 94:534-546
59. Tfayli H, Arslanian S (2009) Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Arq Bras Endocrinol Metab 53:165-174